EUVIMEDOpdag EUVIMED
Leserbrief

Letter: Early Inflammatory Benefit Is Not Yet Equivalent to Durable Surgical Advantage After Colectomy in Colonic Crohn's Disease

Jiacheng Li iD

Alimentary Pharmacology & Therapeutics · 2026-06 · 63 (12) · 1703-1704

DOI: 10.1111/apt.70700 ↗

At a glance

Leserbrief in Alimentary Pharmacology & Therapeutics, published online on 2026-04-25. Written by Jiacheng Li. Institution: Department of Anorectal Surgery, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, China. Cited 1 times so far (Crossref); 5 references.

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Intet abstract tilgængeligt.

Authors and institutions

  • Department of Anorectal Surgery, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, China.

ORCID profiles: Jiacheng Li

Cite

APA

Li, J. (2026). Letter: Early Inflammatory Benefit Is Not Yet Equivalent to Durable Surgical Advantage After Colectomy in Colonic Crohn's Disease. Alimentary Pharmacology & Therapeutics, 63(12), 1703-1704. https://doi.org/10.1111/apt.70700

Vancouver

Li J. Letter: Early Inflammatory Benefit Is Not Yet Equivalent to Durable Surgical Advantage After Colectomy in Colonic Crohn's Disease. Alimentary Pharmacology & Therapeutics. 2026;63(12):1703-1704. doi:10.1111/apt.70700

BibTeX
@article{Li2026,
  author = {Li, Jiacheng},
  title = {Letter: Early Inflammatory Benefit Is Not Yet Equivalent to Durable Surgical Advantage After Colectomy in Colonic Crohn's Disease},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  volume = {63},
  number = {12},
  pages = {1703--1704},
  doi = {10.1111/apt.70700}
}
Start for free →